Omeza Announces Appointment of Brad Scheckner as VP, Field Sales and Operations

Summation

  • “Omeza's rapid ascent from a start-up with a promising concept to a commercial-stage company with an FDA-approved product is a testament to our scientific acumen, robust clinical data, and sound operational infrastructure — one that we continue to build and grow with new talent,” said Cynthia Flowers, Chief Executive Officer of Omeza.
  • Scheckner has served in multiple leadership roles in which he has liaised with marketing, business analytics, and employee engagement teams to develop a cohesive strategic approach that aligns the organization with sales in the pursuit of common goals and objectives.
  • He possesses significant cross-functional expertise in strategic marketing, market and payer access, business analytics, and business development as well as extensive knowledge of target healthcare settings, from specialty practices and ambulatory surgical centers to Veterans Affairs hospitals and the Department of Defense.

Omeza, a regenerative skincare company that develops marine-based therapies for the treatment of chronic wounds, today announced the appointment of Brad Scheckner as Vice President, Field Sales and Operations.

“Omeza’s rapid ascent from a start-up with a promising concept to a commercial-stage company with an FDA-approved product is a testament to our scientific acumen, robust clinical data, and sound operational infrastructure — one that we continue to build and grow with new talent,” said Cynthia Flowers, Chief Executive Officer of Omeza.

“We’re thrilled to have Brad at the helm of our field force to create a culture of empowerment that drives the team to surpass sales targets and generate substantial revenue. His proven success in building teams and launching products is critical as we realize the potential of Omeza’s suite of wound-care products.”

Brad Scheckner brings more than two decades of experience across biopharmaceutical, diagnostic, and medical device companies, including field sales and leadership positions at Genzyme, Sanofi, Crescendo Bioscience, Flexion Therapeutics, and Electromedical Products International. He possesses significant cross-functional expertise in strategic marketing, market and payer access, business analytics, and business development as well as extensive knowledge of target healthcare settings, from specialty practices and ambulatory surgical centers to Veterans Affairs hospitals and the Department of Defense.

Throughout his career, he has built and led multiple first-line management and sales teams, overseeing four product launches across various disease states. Additionally, Mr. Scheckner has served in multiple leadership roles in which he has liaised with marketing, business analytics, and employee engagement teams to develop a cohesive strategic approach that aligns the organization with sales in the pursuit of common goals and objectives.

Mr. Scheckner is a graduate of Florida State University, where he earned his degree in Business Management. He currently resides in Sarasota, Fla.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img
spot_img
spot_img

Stay Connected

spot_img
spot_img

By using this website you agree to accept Medical Device News Magazine Privacy Policy